Dissemination and Implementation (D&I Unit)

What we do

The Dissemination and Implementation Unit’s mission is to support innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines.

Who we are

Miriam Bender, PhD, is an Associate Professor in the Sue & Bill Gross School of Nursing at UC Irvine. She is a care delivery and implementation scientist with a particular interest in understanding the relationships between the organization and implementation of care delivery, multi-professional practice dynamics, and patient care quality and safety outcomes. She was a 2016 Fellow in the NIH Training Institute for Dissemination and Implementation Research in Health (TIDIRH) and currently serves as a reviewer for the NIH Science of Implementation in Health and Healthcare (SIHH) Study Section.
Stephen Schueller, PhD, is an Associate Professor of Psychological Science and Informatics at UC Irvine. He is a clinical psychologist and mental health services researcher whose work focuses on improving the accessibility and availability of mental health services with technology. He was a 2017-2018 fellow in the Implementation Research Institute and serves on the Editorial Board for Implementation Research and Practice.

How we Facilitate Clinical and Translational Science

Defining Dissemination and Implementation

Dissemination refers to active efforts to spread knowledge and innovations based on research findings. Implementation refers to active efforts to increase the integration of evidence-based innovations and interventions into routine, real-world practices and settings.

The Dissemination and Implementation (D&I) Unit at UCI aims to help the UCI community in moving from scientific discovery to broader application locally, regionally, and nationally.

Research efforts that identify, understand, and develop strategies for overcoming barriers to adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines are referred to as dissemination and implementation science. A definition supported by funding announcements in this area released by the National Institute of Health: (PAR-19-274, R01; PAR-19-275, R21; PAR-19-276, R03).

INFORMATIONAL WEBINAR: Dissemination and Implementation Research in Health

Wednesday, June 1, 2022, 3:00 – 4:00 p.m. ET

This webinar will provide an opportunity for investigators to learn about NCI’s participation in the set of NIH announcements, “Dissemination and Implementation Research in Health (R01/R21 - Clinical Trial Optional, R03 – Clinical Trial Not Allowed).” These announcements focus on a broad range of topics across multiple NIH Institutes and Centers to build the knowledge base on the dissemination of evidence and the implementation of a range of evidence-based interventions (including practices, programs, tools, treatments, guidelines, and policies).

As part of this large research agenda, NCI is particularly interested in studies across the cancer control continuum, including in cancer diagnosis, treatment, and survivorship. Examples include (but are not limited to) studies that seek to understand and evaluate sustainable approaches to coordinate cancer treatment across fragmented systems; optimize survivorship care among oncology and non-oncology providers; and improve survivorship care delivery in diverse settings (e.g., community practices, rural settings). NCI is also interested in supporting applications that focus on understanding strategies to promote sustainability and scale-up of effective cancer control interventions; studies that seek to understand de-implementation; studies that seek to advance measures and methods; and studies of the adoption, implementation, and sustainment of cancer control policies.

For more information, see PAR-22-105, PAR-22-106, PAR-22-109).

Participation in the webinar is not required to submit an application. The webinar recording will be archived.

NCI staff will provide an overview of the funding opportunity and application process and address general questions. Please submit questions by 5:00 p.m. ET on Wednesday, May 25, 2022, to NCIdccpsISteam@mail.nih.gov, with “DIRH PAR-22” in the subject line. Questions about individual projects will not be addressed during the session.

Dr. David Chambers
Organization: Division of Cancer Control and Population Sciences (DCCPS)

Dr. Wynne Norton
Organization: National Cancer Institute

Dr. Gila Neta
Organization: National Cancer Institute